ATLASCabaletta Bio (CABA) earnings date: Nov 9, 2026
Cabaletta Bio (CABA) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$0.33.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CABA
| Last price | $1.44 (-4.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Cabaletta Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Cabaletta Bio reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Cabaletta Bio. You can switch it off at any time.
Alert me before CABA reportsFree to start. Creating an account takes under a minute.
Notify me when Cabaletta Bio reports
CABA earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.33 |
| Last report | Aug 13, 2026 · In line |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +53.7% |
| Average move around a report | ±5.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Cabaletta Bio earnings history: last 5 reports
Cabaletta Bio last reported on Aug 13, 2026: EPS of -$0.34 against an estimate of -$0.34 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.34 | -$0.34 | 0.0% | In line | -3.5% |
| May 14, 2026 | -$0.39 | -$0.39 | 0.0% | In line | -7.8% |
| Mar 23, 2026 | -$0.47 | -$0.40 | +14.9% | Beat | -9.2% |
| Feb 25, 2026 | $0.16 | $0.43 | +168.8% | Beat | +5.8% |
| Dec 11, 2025 | -$2.13 | -$0.32 | +85.0% | Beat | -2.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CABA
See the fair value, the probability range and the earnings history of Cabaletta Bio on its ATLAS page.
Cabaletta Bio (CABA) stock analysisPlans from €3.99 a month.
Cabaletta Bio earnings: frequently asked questions
When does Cabaletta Bio (CABA) report earnings?
Cabaletta Bio is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CABA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.33 per share (USD). Estimates can change before the report.
How often does CABA beat earnings estimates?
Of its last 5 reports with a recorded result, Cabaletta Bio beat the EPS estimate 3 times; the average surprise was +53.7%. Past results do not predict the next one.
How much does CABA move around earnings?
Over its last 5 reports the stock moved an average of 5.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Cabaletta Bio beat earnings estimates last quarter?
Cabaletta Bio last reported on Aug 13, 2026: EPS of -$0.34 against an estimate of -$0.34 (0.0% surprise), in line with the estimate.
How much does CABA usually move in a day?
On a normal trading day the ATLAS model puts CABA’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer